Neuroone Medical Technologies (NMTC) Current Assets (2010 - 2026)

Neuroone Medical Technologies (NMTC) has reported Current Assets for 17 consecutive years, with $5.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 43.08% year-over-year to $5.8 million; the trailing twelve-month figure through Jun 2026 stood at $5.8 million (down 43.08% YoY), and the FY2025 full-year result was $10.2 million, up 120.83% from the prior year.
• Current Assets slipped to $5.8 million in Q2 2026 per NMTC's latest filing, from $7.1 million in the prior quarter.
• Across five years, Current Assets topped out at $13.4 million in Q1 2022 and bottomed at $3.8 million in Q1 2025.
• Historically, Current Assets has averaged $7.4 million across 5 years, with a median of $6.7 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Current Assets tumbled 55.36% in 2023, then soared 148.95% in 2025.
• Over 5 years, Current Assets stood at $9.0 million in 2022, then sank by 43.2% to $5.1 million in 2023, then advanced by 12.15% to $5.7 million in 2024, then soared by 41.24% to $8.1 million in 2025, then dropped by 28.24% to $5.8 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $5.8 million, $7.1 million, and $8.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.